Evolocumab, a PCSK9 inhibitor, protects human endothelial cells against H₂O₂-induced oxidative stress

References

• Akbari, V., et al., 2015. Improved biological activity of a single chain antibody fragment against human epidermal growth factor receptor 2 (HER2) expressed in the periplasm of Escherichia coli. Protein expression and purification, 116, 66–74.
   PubMed Web of Science ®Google Scholar
• Aminzadeh, A., 2018. Effect of metformin against hydrogen peroxide-induced apoptosis in human vascular endothelial cells. Iranian journal of physiology and pharmacology, 2 (1), 50–43.
   Google Scholar
• Binti Kamaruddin, N.A., et al., 2020. Cytoprotective role of omentin against oxidative stress-induced vascular endothelial cells injury. Molecules, 25 (11), 2534.
   Google Scholar
• Chen, J., et al., 2010. Propofol protects against hydrogen peroxide-induced oxidative stress and cell dysfunction in human umbilical vein endothelial cells. Molecular and cellular biochemistry, 339 (1–2), 43–54.
   PubMed Web of Science ®Google Scholar
• Chen, Y.Q., Troutt, J.S., and Konrad, R.J., 2014. PCSK9 is present in human cerebrospinal fluid and is maintained at remarkably constant concentrations throughout the course of the day. Lipids, 49 (5), 445–455.
   PubMed Web of Science ®Google Scholar
• Cohen, J.C., et al., 2006. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. The New England journal of medicine, 354 (12), 1264–1272.
   PubMed Web of Science ®Google Scholar
• Ding, Z., et al., 2015a. Hemodynamic shear stress via ROS modulates PCSK9 expression in human vascular endothelial and smooth muscle cells and along the mouse aorta. Antioxidants & redox signaling, 22 (9), 760–771.
   PubMed Web of Science ®Google Scholar
• Ding, Z., et al., 2015b. Cross-talk between LOX-1 and PCSK9 in vascular tissues. Cardiovascular research, 107 (4), 556–567.
   PubMed Web of Science ®Google Scholar
• Ding, Z., et al., 2018. PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy. Cardiovascular research, 114 (13), 1738–1751.
   PubMed Web of Science ®Google Scholar
• Dixon, D.L., et al., 2017. Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up. Drug design, development and therapy, 11, 2121–2129.
   PubMed Web of Science ®Google Scholar
• Hachem, A., et al., 2017. The role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in cardiovascular homeostasis: a non-systematic literature review. Current cardiology reviews, 13 (4), 274–282.
   PubMed Web of Science ®Google Scholar
• Harrison, D., et al., 2003. Role of oxidative stress in atherosclerosis. The American journal of cardiology, 91 (3A), 7A–11A.
   PubMed Web of Science ®Google Scholar
• Lankin, V.Z., et al., 2018. PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases. Terapevticheskii arkhiv, 90 (9), 27–30.
   PubMed Web of Science ®Google Scholar
• Lee, J.S., et al., 2019. PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease. Scientific reports, 9 (1), 17167
   PubMedGoogle Scholar
• Li, J., et al., 2017. Investigation of highly expressed PCSK9 in atherosclerotic plaques and ox-LDL-induced endothelial cell apoptosis. Molecular medicine reports, 16 (2), 1817–1825.
   PubMed Web of Science ®Google Scholar
• Mesripour, A., Iyer, A., and Brown, L., 2012. Mineralocorticoid receptors mediate cardiac remodelling in morphine-dependent rats. Basic & clinical pharmacology & toxicology, 111 (2), 75–80.
   PubMed Web of Science ®Google Scholar
• Mesripour, A., Kavianpour, M., and Hajhashemi, V., 2019. Antidepressant-like effect of minocycline in mice forced swimming test: minor involvement of the noradrenergic system. Thai journal of pharmaceutical sciences, 43 (3), 125–130.
   Google Scholar
• Nadeev, A.D., et al., 2015. [Dual proapoptotic and pronecrotic effect of hydrogen peroxide on human umbilical vein endothelial cells]. Tsitologiia, 57 (12), 909–916.
   PubMedGoogle Scholar
• Norata, G.D., et al., 2012. Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis, 220 (1), 11–21.
   PubMed Web of Science ®Google Scholar
• Ogita, H., and Liao, J., 2004. Endothelial function and oxidative stress. Endothelium: journal of endothelial cell research, 11 (2), 123–132.
   PubMed Web of Science ®Google Scholar
• Poyner, D.R., 1992. Calcitonin gene-related peptide: multiple actions, multiple receptors. Pharmacology & therapeutics, 56 (1), 23–51.
   PubMed Web of Science ®Google Scholar
• Ridker, P.M., et al., 2012. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. The Lancet, 380 (9841), 565–571.
   PubMed Web of Science ®Google Scholar
• Schulz, E., Anter, E., and Keaney, J.F., Jr., 2004. Oxidative stress, antioxidants, and endothelial function. Current medicinal chemistry, 11 (9), 1093–1104.
   PubMed Web of Science ®Google Scholar
• Seidah, N.G., et al., 2013. The multifaceted proprotein convertases: their unique, redundant, complementary, and opposite functions. The journal of biological chemistry, 288 (30), 21473–21481.
   PubMed Web of Science ®Google Scholar
• Seyfizadeh, N., et al., 2012. Cytoprotective effects of arbutin against tert-butyl hydroperoxid induced toxicity in Hep-G2 cell line. World applied sciences journal, 19 (2), 163–167.
   Google Scholar
• Sharotri, V., et al., 2012. Regulation of epithelial sodium channel trafficking by proprotein convertase subtilisin/kexin type 9 (PCSK9). The journal of biological chemistry, 287 (23), 19266–19274.
   PubMed Web of Science ®Google Scholar
• Tang, Z.H., et al., 2017. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway. Atherosclerosis, 262 (2), 113–122.
   PubMedGoogle Scholar
• Urban, D., et al., 2013. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis. Journal of the American college of cardiology, 62 (16), 1401–1408.
   PubMed Web of Science ®Google Scholar
• Wang, X., et al., 2017. Roles of miR-4463 in H2O2-induced oxidative stress in human umbilical vein endothelial cells. Molecular medicine reports, 16 (3), 3242–3252.
   PubMed Web of Science ®Google Scholar
• Wei, Z., et al., 2003. Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide. Journal of neuroscience research, 73 (3), 364–368.
   PubMed Web of Science ®Google Scholar
• WHO. 2017. Cardiovascular diseases (CVDs) fact sheet Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) [Accessed 15 March 2020].
   Google Scholar
• Wolf, S.P., 1994. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods in enzymology, 233 (2), 182–189.
   Google Scholar
• Wu, C.Y., et al., 2012. PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway. Molecular and cellular biochemistry, 359 (1–2), 347–358.
   PubMed Web of Science ®Google Scholar
• Wu, D., et al., 2014. Antioxidant properties of Lactobacillus and its protecting effects to oxidative stress Caco-2 cells. The journal of animal and plant sciences, 24 (6), 1766–1771.
   Web of Science ®Google Scholar
• Yang, X., et al., 2017. Oxidative stress-mediated atherosclerosis: mechanisms and therapies. Frontiers in physiology, 8, 600.
   PubMed Web of Science ®Google Scholar